Skip Nav Destination
Abstract CT100: First-in-human phase 1 trial of pyrimidine anti-metabolite FF-10502-01 in patients with advanced cancer
Cancer Res (2017) 77 (13_Supplement): CT100.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Shinji Mima
- Chihaya Kakinuma
- Tamami Higuchi
- Kazunori Saeki
- Takayuki Yamada
- Rena Uematsu
- Miki Ishino
- Nobuko Kito
- Hiroki Nishikawa
- Hidenobu Kuniyoshi
- Takuya Matsumoto
- Hideyasu Fujiwara
- Linda J. Paradiso
- Yasuhiro Shimada
- Hiroyuki Iwamura
Journal of Pharmacology and Experimental Therapeutics (2018) 366 (1): 125.
